Immunovant, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionGhost Tree Capital, LLC
Latest Disclosed Ownership215,000 shares
Latest Disclosed Value $ 6,129,650
Ghost Tree Capital, LLC ownership in IMVT / Immunovant, Inc.

On November 14, 2024 - Ghost Tree Capital, LLC filed a 13F-HR form disclosing ownership of 215,000 shares of Immunovant, Inc. (US:IMVT) valued at $6,129,650 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 14, 2024 disclosing 260,000 shares of Immunovant, Inc.. This represents a change in shares of -17.31% during the quarter. The current value of the position is $6,697,250 USD.

Ghost Tree Capital, LLC has a history of taking positions in derivatives of the underlying security (IMVT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IMVT / Immunovant, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-11-14 2024-09-30 13F IMMUNOVANT COM 45258J102 215,000 -45,000 -17.31 6,130 -10.71 1.8516
2024-08-14 2024-06-30 13F IMMUNOVANT COM 45258J102 260,000 135,000 108.00 6,864 69.99 2.1494
2024-05-15 2024-03-31 13F IMMUNOVANT COM 45258J102 125,000 125,000 4,039 1.1179
2024-02-14 2023-12-31 13F IMMUNOVANT COM 45258J102 0 -130,000 -100.00 0 -100.00
2023-11-14 2023-09-30 13F IMMUNOVANT COM 45258J102 130,000 130,000 4,991 1.6413
2021-08-10 2021-06-30 13F IMMUNOVANT COM 45258J102 0 -250,000 -100.00 0 -100.00
2021-08-11 2021-03-31 13F/A-1 IMMUNOVANT COM 45258J102 250,000 -50,000 -16.67 4,010 -71.06 0.9425
2021-05-14 2021-03-31 13F IMMUNOVANT COM 45258J102 250,000 -50,000 4,010 0.9425
2021-02-18 2020-12-31 13F/A-1 IMMUNOVANT COM 45258J102 300,000 -225,000 -42.86 13,857 -25.00 3.0877
2021-02-16 2020-12-31 13F IMMUNOVANT COM 45258J102 300,000 -225,000 13,857 3,013,976.9183
2020-11-16 2020-09-30 13F IMMUNOVANT COM 45258J102 525,000 0 0.00 18,475 44.52 5.3398
2020-08-14 2020-06-30 13F IMMUNOVANT COM 45258J102 525,000 -185,000 -26.06 12,784 15.68 3.3729
2020-05-15 2020-03-31 13F IMMUNOVANT COM 45258J102 710,000 -90,000 -11.25 11,051 -12.96 2.9310
2020-04-09 2019-12-31 13F/A-2 IMMUNOVANT COM 45258J102 800,000 800,000 12,696 2.4178
2020-02-14 2019-12-31 13F IMMUNOVANT COM 45258J102 800,000 12,696 2.4017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F IMMUNOVANT COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F IMMUNOVANT COM Call 150,000 4,846 n/a n/a n/a
2022-02-16 2021-12-31 13F IMMUNOVANT COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F IMMUNOVANT COM Call 200,000 0.00 1,738 -17.79 n/a n/a n/a
2021-08-11 2021-06-30 13F IMMUNOVANT COM Call 200,000 2,114 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-02-14 2023-12-31 13F IMMUNOVANT COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F IMMUNOVANT COM Put 85,000 3,263 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.